RH&PARTNER Investment Funds SICAV-RH&P Global Life Sciences Fund I Cap CHF/ LU1120849671 /
| NAV8/22/2024 | Chg.-0.7200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 93.3000CHF | -0.77% | reinvestment | Equity Worldwide | FundPartner Sol.(EU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 4.24 | -4.03 | -5.75 | 2.46 | -1.14 | 5.64 | -2.48 | 3.04 | -4.81 | -0.72 | -5.75 | 2.19 | -7.71% |
| 2022 | -8.93 | -2.22 | 3.21 | -8.15 | -0.80 | 0.65 | 2.61 | -2.58 | -4.48 | 8.48 | 6.52 | -1.81 | -8.70% |
| 2023 | 3.80 | -6.78 | 0.09 | -2.33 | -0.44 | -1.29 | 2.44 | -1.60 | -5.53 | -8.57 | 5.39 | 9.29 | -6.76% |
| 2024 | -3.19 | 0.91 | 2.13 | -5.36 | 2.68 | 4.58 | 4.75 | 2.29 | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.23% | 14.21% | 15.37% | 20.18% | -% |
| Sharpe ratio | 0.73 | 1.41 | 0.35 | -0.45 | - |
| Best month | +9.29% | +4.75% | +9.29% | +9.29% | - |
| Worst month | -5.36% | -5.36% | -8.57% | -8.93% | - |
| Maximum loss | -9.88% | -8.87% | -14.42% | -33.61% | - |
| Outperformance | - | - | - | - | - |
All quotes in CHF
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| RH&P Glob. Life Sciences Fd. I c... | paying dividend | 99.8300 | +11.53% | -12.18% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 93.3000 | +8.88% | -15.52% | |
| RH&PARTNER Investment Funds SICA... | reinvestment | 186.3000 | +12.98% | -8.07% |
Performance
| YTD | +8.65% | ||
|---|---|---|---|
| 6 Months | +11.11% | ||
| 1 Year | +8.88% | ||
| 3 Years | -15.52% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | -14.64% | ||
| Year | |||
| 2023 | -6.76% | ||
| 2022 | -8.70% | ||
| 2021 | -7.71% | ||
